New patent for Pf Prism drug INLYTA

   January 23, 2021    Comments Off on New patent for Pf Prism drug INLYTA    Posted in: Patent Added

Annual Drug Patent Expirations for INLYTA Inlyta is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are four…

The post New patent for Pf Prism drug INLYTA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog